Moderna
MRNA
#1830
Rank
โ‚ฌ9.29 B
Marketcap
23,79ย โ‚ฌ
Share price
8.67%
Change (1 day)
-43.44%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Revenue for Moderna (MRNA)

Revenue in 2025 (TTM): โ‚ฌ1.98 Billion

According to Moderna 's latest financial reports the company's current revenue (TTM ) is โ‚ฌ1.89 Billion. In 2024 the company made a revenue of โ‚ฌ3.07 Billion a decrease over the revenue in the year 2023 that were of โ‚ฌ6.10 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Moderna from 2018 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) โ‚ฌ1.98 B-35.34%
2024 โ‚ฌ3.07 B-49.68%
2023 โ‚ฌ6.10 B-65.28%
2022 โ‚ฌ17.59 B12.36%
2021 โ‚ฌ15.66 B6920.59%
2020 โ‚ฌ0.22 B420.22%
2019 โ‚ฌ42.88 M-60.04%
2018 โ‚ฌ0.10 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Regulus Therapeutics
RGLS
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚ฌ55.17 B 2,817.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
โ‚ฌ0.06 M-100.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
โ‚ฌ2.75 B 45.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚ฌ48.41 B 2,460.04%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Arrowhead Pharmaceuticals
ARWR
โ‚ฌ0.49 B-73.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
โ‚ฌ79.14 B 4,084.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
โ‚ฌ0.16 B-91.24%๐Ÿ‡บ๐Ÿ‡ธ USA